HAEMOPHILUS INFLUENZAE TYPE B-PRP — all Canadian products
4 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is HAEMOPHILUS INFLUENZAE TYPE B-PRP, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 01959034 | ACT-HIB | SANOFI VACCINES CANADA LTD. | Powder For Solution; Kit | Intramuscular | HAEMOPHILUS INFLUENZAE TYPE B-PRP 10 MCG; TETANUS PROTEIN 30 MCG | Marketed | |
| 02235721 | LIQUID PEDVAXHIB | MERCK CANADA INC | Suspension | Intramuscular | HAEMOPHILUS INFLUENZAE TYPE B-PRP 7.5 MCG; NEISSERIA MENINGITIDIS OUTER MEMBRANE PROTEIN COMPLEX 125 MCG | Cancelled Post Market | |
| 01942948 | PEDVAXHIB INJ PWS | MERCK MANUFACTURING DIVISION, DIVISION OF MERCK & CO., INC. | Powder For Solution | Intramuscular | HAEMOPHILUS INFLUENZAE TYPE B-PRP 15 MCG; NEISSERIA MENINGITIDIS OUTER MEMBRANE PROTEIN COMPLEX 250 MCG | Cancelled Post Market | |
| 00764221 | PROHIBIT INJ VACCINE | AVENTIS PASTEUR LIMITED | Liquid | Intramuscular | HAEMOPHILUS INFLUENZAE TYPE B-PRP 25 MCG; DIPHTHERIA TOXOID 23 MCG | Cancelled Post Market |
Browse other molecules: